We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AGILITY:ADXAgility Global PLC Analysis

Data as of 2026-03-16 - not real-time

$2.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Agility Capital Holding Inc. is trading at $2.50, well below its 20‑day, 50‑day and 200‑day moving averages (2.56, 2.71 and 2.73 respectively), signaling a bearish price environment. The MACD line sits just under its signal line and the RSI hovers around 40, suggesting limited upside momentum and a modestly oversold condition. Volatility is exceptionally high at over 70% for the past month, while beta is near zero, indicating price swings are largely independent of broader market moves. On the valuation side, the price‑to‑book ratio of 0.69 and a discounted cash‑flow fair value of roughly $50 point to a massive discount, yet the company posts a negative profit margin of –13%, a ROE of –11% and a debt‑to‑equity ratio above 200%, highlighting serious financial strain. Liquidity is thin, with a market cap under $2 million and daily volumes well below its 3‑month average, compounding execution risk. No dividend is paid and recent news offers no material catalyst, leaving the stock’s upside hinging on a turnaround of its operating performance and debt restructuring.
Given the stark contrast between the deep valuation gap and the deteriorated fundamentals, investors face a classic value‑versus‑risk dilemma. Short‑term prospects appear limited as technical indicators remain bearish and cash flow is constrained, while the long‑term narrative depends on whether the company can unlock the intrinsic value implied by the DCF model amid its high leverage and emerging‑market exposure.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below all major moving averages
  • Bearish MACD and decreasing volume
  • Negative earnings and high leverage

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential support at $2.50
  • Valuation discount versus DCF
  • Continued earnings pressure

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • DCF fair value far above current price
  • Low price‑to‑book ratio
  • Opportunity if debt restructuring succeeds

Key Metrics & Analysis

Financial Health

Revenue Growth4.10%
Profit Margin-13.26%
ROE-10.97%
ROA4.53%
Debt/Equity215.21
P/B Ratio0.7
Op. Cash Flow$1.2M
Free Cash Flow$2.5M
Industry P/E32.5

Technical Analysis

TrendBearish
RSI40.5
Support$2.50
Resistance$2.68
MA 20$2.56
MA 50$2.71
MA 200$2.73
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value$50.07
GradeUndervalued
TypeValue

Risk Assessment

Beta-0.03
Volatility70.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.